Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chitosan-based nanoparticles for topical genetic immunization.

Z Cui1, R J Mumper

  • 1Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Rose Street, Lexington, KY 40536-0082, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|August 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Chicory reduces enteric methane emissions and maintains milk yield but decreases milk fat content compared with perennial ryegrass in dairy cows.

Journal of dairy science·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

A novel BRCA mutation classification system reveals differential responses to PARP inhibition and prognostic outcomes in epithelial ovarian cancer: a multicenter study.

ESMO open·2026
Same journal

Endogenous-metabolite-inspired polyamine-oleic acid lipids for safe mRNA delivery and PCSK9 gene editing.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Tunable rigid spikes on virus-like porous silica enable mechanistically controlled nanovaccine platforms.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Metabolic regulation-driven nanoparticles for tumor vulnerabilization and enhanced photodynamic therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

A cation-free platform based on azocalixarene poly(disulfide)s for direct cytosolic protein delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Harnessing plant-derived extracellular vesicles for oral delivery: A dual role as natural therapeutics and engineered drug carriers.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles

Topical application of chitosan nanoparticles carrying plasmid DNA offers a promising needle-free method for genetic immunization. This approach successfully demonstrated gene expression and induced an immune response in mouse models.

Area of Science:

  • Biotechnology
  • Immunology
  • Materials Science

Background:

  • Genetic vaccines show promise for infectious diseases in animal models.
  • Direct targeting of skin dendritic cells is validated but needle-free device viability is uncertain.
  • Investigating alternative topical delivery systems for genetic immunization is crucial.

Purpose of the Study:

  • To explore chitosan-based nanoparticles for topical plasmid DNA delivery for genetic immunization.
  • To develop and characterize nanoparticles for efficient gene delivery to the skin.
  • To evaluate the immunogenicity of the developed genetic vaccine formulation.

Main Methods:

  • Formulation of two types of chitosan-based nanoparticles: pDNA-condensed and pDNA-coated on chitosan/carboxymethylcellulose (CMC) nanoparticles.

Related Experiment Videos

  • Characterization of nanoparticle stability in serum.
  • Topical application of nanoparticles onto mouse skin and assessment of gene expression (luciferase) and immune response (antigen-specific IgG titer to beta-galactosidase).

    • Main Results:

    • Stable cationic nanoparticles were formed by complexing chitosan with CMC for pDNA coating.
    • pDNA-coated nanoparticles showed stability against serum challenge.
    • Topical application resulted in detectable luciferase expression in mouse skin and significant antigen-specific IgG titers.

    Conclusions:

    • Chitosan-based nanoparticles provide a viable platform for topical genetic immunization.
    • This needle-free approach demonstrates effective gene delivery and induction of antigen-specific immune responses.
    • Further development could lead to commercially viable genetic vaccines.